The Hill (6/1, Hellmann) reports the FDA “is reporting shortages of Zoloft [sertraline] and the generic version of the antidepressant as demand soars and supply chains for key ingredients are interrupted by the pandemic.” Pfizer told the agency “it has a limited supply [of Zoloft] available of the 100-count bottles of 100-milligram pills due to” an increase in demand, and other manufacturers reported shortages of generic versions.
Bloomberg (6/1, Edney) reports, “Zoloft prescriptions climbed 12% year-over-year to 4.9 million in March, the most ever in the U.S., according to data compiled by Bloomberg Intelligence.”
Related Links:
— “Zoloft shortages reported amid increased demand, strained supply lines, “Jessie Hellmann, The Hill, June 1, 2020